patents.google.com

ECSP982486A - PROTEASE INHIBITORS II - Google Patents

  • ️Tue Jan 12 1999

ECSP982486A - PROTEASE INHIBITORS II - Google Patents

PROTEASE INHIBITORS II

Info

Publication number
ECSP982486A
ECSP982486A ECSP982486A ECSP982486A EC SP982486 A ECSP982486 A EC SP982486A EC SP982486 A ECSP982486 A EC SP982486A EC SP982486 A ECSP982486 A EC SP982486A Authority
EC
Ecuador
Prior art keywords
disease
cartilage
present
matrix
excessive
Prior art date
1998-04-27
Application number
Other languages
Spanish (es)
Inventor
Stacie Marie Halbert
Evelyne Michaud
Scott Kevin Thompson
Daniel Frank Verber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1998-04-27
Filing date
1998-04-27
Publication date
1999-01-12
1998-04-27 Application filed filed Critical
1998-04-27 Priority to ECSP982486 priority Critical patent/ECSP982486A/en
1999-01-12 Publication of ECSP982486A publication Critical patent/ECSP982486A/en

Links

  • 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
  • 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
  • 150000001875 compounds Chemical class 0.000 abstract 3
  • 210000000845 cartilage Anatomy 0.000 abstract 2
  • 230000015556 catabolic process Effects 0.000 abstract 2
  • 238000006731 degradation reaction Methods 0.000 abstract 2
  • 201000010099 disease Diseases 0.000 abstract 2
  • 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
  • 239000011159 matrix material Substances 0.000 abstract 2
  • 208000020084 Bone disease Diseases 0.000 abstract 1
  • 206010065687 Bone loss Diseases 0.000 abstract 1
  • 102000004171 Cathepsin K Human genes 0.000 abstract 1
  • 108090000625 Cathepsin K Proteins 0.000 abstract 1
  • 208000037147 Hypercalcaemia Diseases 0.000 abstract 1
  • 208000010191 Osteitis Deformans Diseases 0.000 abstract 1
  • 208000001132 Osteoporosis Diseases 0.000 abstract 1
  • 208000027868 Paget disease Diseases 0.000 abstract 1
  • 102000035195 Peptidases Human genes 0.000 abstract 1
  • 108091005804 Peptidases Proteins 0.000 abstract 1
  • 239000004365 Protease Substances 0.000 abstract 1
  • 208000024693 gingival disease Diseases 0.000 abstract 1
  • 208000007565 gingivitis Diseases 0.000 abstract 1
  • 230000000148 hypercalcaemia Effects 0.000 abstract 1
  • 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
  • 230000003211 malignant effect Effects 0.000 abstract 1
  • 208000027202 mammary Paget disease Diseases 0.000 abstract 1
  • 238000000034 method Methods 0.000 abstract 1
  • 239000008194 pharmaceutical composition Substances 0.000 abstract 1
  • 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona compuestos que inhiben proteasas, incluyendo catepsina K, composiciones farmacéuticas de tales compuestos, y métodos para tratar enfermedades de excesiva pérdida ósea o degradación de cartílago o matriz, incluyendo osteoporosis; enfermedad gingival, incluyendo gingivitis y artritis reumatoide; enfermedad de Paget: hipercalcemia de enfermedades malignas; y enfermedad ósea o degradación excesiva de cartílago o matriz administrando un compuesto de la presente invención a un paciente con necesidad de ello.The present invention provides compounds that inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods of treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease, including gingivitis and rheumatoid arthritis; Paget's disease: hypercalcemia of malignant diseases; and bone disease or excessive degradation of cartilage or matrix by administering a compound of the present invention to a patient in need thereof.

ECSP982486 1998-04-27 1998-04-27 PROTEASE INHIBITORS II ECSP982486A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982486 ECSP982486A (en) 1998-04-27 1998-04-27 PROTEASE INHIBITORS II

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982486 ECSP982486A (en) 1998-04-27 1998-04-27 PROTEASE INHIBITORS II

Publications (1)

Publication Number Publication Date
ECSP982486A true ECSP982486A (en) 1999-01-12

Family

ID=42043408

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982486 ECSP982486A (en) 1998-04-27 1998-04-27 PROTEASE INHIBITORS II

Country Status (1)

Country Link
EC (1) ECSP982486A (en)

Similar Documents

Publication Publication Date Title
AP9801222A0 (en) 1998-06-30 Proatease inhibitors.
NO20013124D0 (en) 2001-06-22 Protease inhibitors
MY141596A (en) 2010-05-31 Protease inhibitors
TR199902703T2 (en) 2000-02-21 Protease inhibitors.
WO1999059526A3 (en) 2000-01-20 Protease inhibitors
MXPA02012442A (en) 2003-04-25 Protease inhibitors.
UY26088A1 (en) 2000-10-31 PROTEASE INHIBITORS
UY26026A1 (en) 2000-10-31 PROTEASE INHIBITORS
WO2002092563A3 (en) 2003-04-03 Protease inhibitors
ECSP982486A (en) 1999-01-12 PROTEASE INHIBITORS II
UY27032A1 (en) 2002-07-31 PROTEASE INHIBITORS
ECSP982481A (en) 1999-01-19 PROTEASE INHIBITORS
ECSP992959A (en) 1999-10-06 BIS-AMINOMETIL CARBONYL PROTEASE INHIBITORS
UY24550A1 (en) 2001-10-25 PROTEASE INHIBITORS
ECSP003403A (en) 2000-05-25 PROTEASE INHIBITORS XI
ECSP982493A (en) 1999-01-12 PROTEASE INHIBITORS III
ECSP993293A (en) 2000-05-25 PROTEASE INHIBITORS VIII
AR021971A1 (en) 2002-09-04 PROTEASE INHIBITORS
UY26771A1 (en) 2002-01-31 PROTEASE INHIBITORS
NZ324101A (en) 1999-11-29 Protease inhibitors, pharmaceutical compositions and use thereof
ECSP003353A (en) 2000-06-19 PROTEASE INHIBITORS IX
AR004703A1 (en) 1999-03-10 HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES.